Le Lézard
Classified in: Health, Covid-19 virus
Subject: AWD

Joyce J. Cottrell, RN, BSN is recognized by Continental Who's Who


COLUMBIA, Md., Nov. 30, 2021 /PRNewswire/ -- Joyce J. Cottrell, RN, BSN, is being recognized as a Trusted Nurse for her work in the Medical field and in recognition of her work at Senior Care Venture Providers LLC.

Ms. Cottrell works as the Founder and Registered Nurse at Senior Care Venture Providers LLC, in Gaithersburg, MD. Ms. Cottrell has over 20 years of experience in the nursing field, and has aided countless patients throughout her long career. When Ms. Cottrell's husband was going through cancer treatment, they saw many older people who came alone and unaided for chemotherapy, and who clearly needed help. After her husband passed away in 2018, Ms. Cottrell started the company to give back to her community and provide various types of home elder care, allowing patients to stay in their homes while receiving long-term care. In other aspects of her work, Ms. Cottrell works as a delegating nurse clinical instructor, and has worked on the front lines during the ongoing COVID-19 pandemic. 

The Ada Cottrell Foundation, named after Ms. Cottrell's eight-year-old daughter, is a nonprofit that provides support, education, research, resources, and innovation to the health sector. The Foundation now has 32 employees dedicated to helping the healthcare community and those who are battling cancer. The Ada Cottrell Foundation raises funds to invest in the research and development of innovative health solutions. In recent projects, the Foundation provided school supplies to children in need, and has delivered health supplies to those who require them.

She earned a Bachelor of Science in Nursing degree from Stellenbosch University, in Cape Town, South Africa, in 2004. She is also certified in Advanced Cardiac Life Support (ACLS), and she is working toward getting her Forensic Nurse Examiner Licensure. To remain aware of developments in the field, she maintains active affiliations with the American Nurses Association, the Tanzanian Community Association, and the International Women's Leadership Association.

Awards for Ms. Cottrell's work include recognition as a Woman of Outstanding Leadership from the International Women's Leadership Association, Top Female Executive for Outstanding Professional Excellence and Dedication, and inclusion in the 2016 Worldwide Publishing's Prestigious Roster. She has been recognized on IssueWire.

On a personal note, she enjoys gardening and eating her homegrown vegetables. She also loves traveling, running, and swimming.

For more information, visit www.adacottrellfoundation.org and  https://seniorcareventureproviders.org/.

Contact: Katherine Green , 516-825-5634 pr@continentalwhoswho.com

SOURCE Continental Who's Who


These press releases may also interest you

at 03:01
Nova Mentis Life Science Corp. ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is proud to announce that the Company...

at 03:00
SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has appointed Professor Michael J. Econs, MD as Clinical Advisor. Distinguished Professor of Medicine and Medical and Molecular Genetics at...

at 03:00
iSwap, a cross-chain transaction platform, announced the launch of iSwap V5, the latest upgrade to its system today. Through this upgrade, iSwap aims to improve the user experience for cross-chain DeFi transactions. The upgrade consists of two...

at 03:00
NJ Top Docs has reviewed and approved Dr. Cherag Daruwala of Hunterdon Gastroenterology Associates for 2021. This is Dr. Daruwala's sixth consecutive year being reviewed and approved by NJ Top Docs. Dr. Daruwala is a board certified...

at 02:23
Ready to capitalize on a strong foundation Q4 2021 highlights Total net revenues of SEK 144.0 m (159.2) Net earnings of SEK -66.0 m (-49.6) EBITDA of SEK -48.5 m (1.0) US Pharma segment (ZUBSOLV® US) net revenues of SEK 133.6 m (143.1), in local...

at 02:15
Epizyme, Inc. , a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced the pricing of an underwritten public offering of 56,666,667 shares of its common stock at a price to...



News published on 30 november 2021 at 22:55 and distributed by: